EP3714877
Aðferð og samsetning til að meðhöndla augnháþrýsting og gláku
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.5.2009EP published:
26.1.2022EP application number:
20164602.3
EP translation filed:
2.2.2022Grant published:
15.3.2022EPO information:
European Patent Register
Max expiry date:
27.5.2029Expiry date:
27.5.2026Next due date:
31.5.2026
Title in English:
METHOD AND COMPOSITION FOR TREATING OCULAR HYPERTENSION AND GLAUCOMALanguage of the patent:
English
Timeline
Today
28.5.2009EP application
26.1.2022EP Publication
2.2.2022Translation submitted
15.3.2022Registration published
27.5.2026Expires
Owner
Name:
Santen Pharmaceutical Co., Ltd.Address:
4-20, Ofuka-cho, Kita-ku Osaka-shi Osaka 530-8552, JP
Name:
AGC Inc.Address:
5-1, Marunouchi 1-chome, Chiyoda-ku Tokyo 100-8405, JP
Inventor
Name:
Reunamaki, TimoAddress:
33820 Tampere, FI
Name:
Pellinen, PerttiAddress:
33880 Lempaala, FI
Name:
Oksala, OlliAddress:
33240 Tampere, FI
Name:
Lehmussaari, KariAddress:
33580 Tampere, FI
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
08397513Date:
30.5.2008Country:
EP
Classification
Categories:
A61K 9/08, A61K 47/10, A61K 47/26, A61K 47/18, A61K 31/5575
Annual fees
Number
Paid
Expires
Payer
Number: 14
Paid: 12.5.2022
Expires: 27.5.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 15
Paid: 12.4.2023
Expires: 27.5.2024
Payer: Árnason Faktor ehf.
Number: 16
Paid: 9.4.2024
Expires: 27.5.2025
Payer: Árnason Faktor ehf.
Number: 17
Paid: 9.5.2025
Expires: 27.5.2026
Payer: Árnason Faktor ehf.